Lonza Group AG (OTCMKTS:LZAGY) to Post FY2025 Earnings of $1.81 Per Share, William Blair Forecasts

Lonza Group AG (OTCMKTS:LZAGY) – Research analysts at William Blair raised their FY2025 EPS estimates for shares of Lonza Group in a research note issued to investors on Thursday, July 25th. William Blair analyst M. Smock now anticipates that the company will post earnings per share of $1.81 for the year, up from their prior estimate of $1.75. The consensus estimate for Lonza Group’s current full-year earnings is $1.38 per share.

Separately, Berenberg Bank raised shares of Lonza Group to a “strong-buy” rating in a research report on Sunday, June 23rd.

Lonza Group Stock Performance

Shares of OTCMKTS LZAGY opened at $65.65 on Monday. The firm’s 50 day moving average price is $56.22 and its 200-day moving average price is $54.75. Lonza Group has a 52-week low of $34.19 and a 52-week high of $66.02. The company has a current ratio of 1.77, a quick ratio of 1.20 and a debt-to-equity ratio of 0.27.

Lonza Group Cuts Dividend

The firm also recently declared a dividend, which was paid on Wednesday, May 29th. Stockholders of record on Thursday, May 16th were issued a dividend of $0.0995 per share. The ex-dividend date was Wednesday, May 15th.

About Lonza Group

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing.